Come up with a name for your new list and we'll add to it:
Kineta raised a round of funding on April 08, 2011. Investors include
National Institutes of Health.
Kineta is a nationally-recognized biotechnology company focused on developing leading edge therapeutics in three large high need therapeutic areas: autoimmune disease, viral disease and chronic pain. …